This groundbreaking global conference will redefine the future of oncology drug development by challenging conventional paradigms and catalyzing innovation across disciplines. Bringing together a diverse and influential community—including leaders from biotech, pharma, academia, regulatory agencies, technology, venture capital, and patient advocacy—this conference is being launched to spark bold ideas and foster transformative collaborations.
